Review





Similar Products

human il 2 research grade  (Miltenyi Biotec)
99
Miltenyi Biotec human il 2 research grade
Human Il 2 Research Grade, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human il 2 research grade/product/Miltenyi Biotec
Average 99 stars, based on 1 article reviews
human il 2 research grade - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier
human il2  (MedChemExpress)
95
MedChemExpress human il2
Human Il2, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human il2/product/MedChemExpress
Average 95 stars, based on 1 article reviews
human il2 - by Bioz Stars, 2026-02
95/100 stars
  Buy from Supplier
recombinant human il 2  (Miltenyi Biotec)
94
Miltenyi Biotec recombinant human il 2
Recombinant Human Il 2, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant human il 2/product/Miltenyi Biotec
Average 94 stars, based on 1 article reviews
recombinant human il 2 - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier
human il 2 hil 2  (Miltenyi Biotec)
99
Miltenyi Biotec human il 2 hil 2
( A ) The IFN-⍺ + , TNFα + , and GrzB + population (%) of <t>IL-2–activated</t> NK cells after antibodies treatment with different NKG2A binding valency (monovalent, bivalent, tetravalent, or multivalent) in the coculture system with A549 cells, E:T ratio of 5:1, for 24 hours. ( B ) Internalization of NKG2A antibodies in NK cells, assessed by labeling the antibody with a pH-sensitive dye to monitor endocytosis. Durvalumab and pertuzumab (ptz IgG1) were included as controls. (A and B) Each symbol represents the value obtained from individual healthy donors. Significance was determined by one-way ANOVA with the Tukey’s post hoc test, * P < 0.05, ** P < 0.01, *** P < 0.001, and **** P < 0.0001.
Human Il 2 Hil 2, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human il 2 hil 2/product/Miltenyi Biotec
Average 99 stars, based on 1 article reviews
human il 2 hil 2 - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier
interleukin 2 il2  (Miltenyi Biotec)
97
Miltenyi Biotec interleukin 2 il2
( A ) The IFN-⍺ + , TNFα + , and GrzB + population (%) of <t>IL-2–activated</t> NK cells after antibodies treatment with different NKG2A binding valency (monovalent, bivalent, tetravalent, or multivalent) in the coculture system with A549 cells, E:T ratio of 5:1, for 24 hours. ( B ) Internalization of NKG2A antibodies in NK cells, assessed by labeling the antibody with a pH-sensitive dye to monitor endocytosis. Durvalumab and pertuzumab (ptz IgG1) were included as controls. (A and B) Each symbol represents the value obtained from individual healthy donors. Significance was determined by one-way ANOVA with the Tukey’s post hoc test, * P < 0.05, ** P < 0.01, *** P < 0.001, and **** P < 0.0001.
Interleukin 2 Il2, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/interleukin 2 il2/product/Miltenyi Biotec
Average 97 stars, based on 1 article reviews
interleukin 2 il2 - by Bioz Stars, 2026-02
97/100 stars
  Buy from Supplier
human il 2  (Miltenyi Biotec)
99
Miltenyi Biotec human il 2
( A ) The IFN-⍺ + , TNFα + , and GrzB + population (%) of <t>IL-2–activated</t> NK cells after antibodies treatment with different NKG2A binding valency (monovalent, bivalent, tetravalent, or multivalent) in the coculture system with A549 cells, E:T ratio of 5:1, for 24 hours. ( B ) Internalization of NKG2A antibodies in NK cells, assessed by labeling the antibody with a pH-sensitive dye to monitor endocytosis. Durvalumab and pertuzumab (ptz IgG1) were included as controls. (A and B) Each symbol represents the value obtained from individual healthy donors. Significance was determined by one-way ANOVA with the Tukey’s post hoc test, * P < 0.05, ** P < 0.01, *** P < 0.001, and **** P < 0.0001.
Human Il 2, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human il 2/product/Miltenyi Biotec
Average 99 stars, based on 1 article reviews
human il 2 - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier
interleukin 2  (Cusabio)
91
Cusabio interleukin 2
( A ) The IFN-⍺ + , TNFα + , and GrzB + population (%) of <t>IL-2–activated</t> NK cells after antibodies treatment with different NKG2A binding valency (monovalent, bivalent, tetravalent, or multivalent) in the coculture system with A549 cells, E:T ratio of 5:1, for 24 hours. ( B ) Internalization of NKG2A antibodies in NK cells, assessed by labeling the antibody with a pH-sensitive dye to monitor endocytosis. Durvalumab and pertuzumab (ptz IgG1) were included as controls. (A and B) Each symbol represents the value obtained from individual healthy donors. Significance was determined by one-way ANOVA with the Tukey’s post hoc test, * P < 0.05, ** P < 0.01, *** P < 0.001, and **** P < 0.0001.
Interleukin 2, supplied by Cusabio, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/interleukin 2/product/Cusabio
Average 91 stars, based on 1 article reviews
interleukin 2 - by Bioz Stars, 2026-02
91/100 stars
  Buy from Supplier
anti il 2 apc reafinitytm  (Miltenyi Biotec)
97
Miltenyi Biotec anti il 2 apc reafinitytm
( A ) The IFN-⍺ + , TNFα + , and GrzB + population (%) of <t>IL-2–activated</t> NK cells after antibodies treatment with different NKG2A binding valency (monovalent, bivalent, tetravalent, or multivalent) in the coculture system with A549 cells, E:T ratio of 5:1, for 24 hours. ( B ) Internalization of NKG2A antibodies in NK cells, assessed by labeling the antibody with a pH-sensitive dye to monitor endocytosis. Durvalumab and pertuzumab (ptz IgG1) were included as controls. (A and B) Each symbol represents the value obtained from individual healthy donors. Significance was determined by one-way ANOVA with the Tukey’s post hoc test, * P < 0.05, ** P < 0.01, *** P < 0.001, and **** P < 0.0001.
Anti Il 2 Apc Reafinitytm, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti il 2 apc reafinitytm/product/Miltenyi Biotec
Average 97 stars, based on 1 article reviews
anti il 2 apc reafinitytm - by Bioz Stars, 2026-02
97/100 stars
  Buy from Supplier
eamg ld il 2 group  (MedChemExpress)
96
MedChemExpress eamg ld il 2 group
( A ) The IFN-⍺ + , TNFα + , and GrzB + population (%) of <t>IL-2–activated</t> NK cells after antibodies treatment with different NKG2A binding valency (monovalent, bivalent, tetravalent, or multivalent) in the coculture system with A549 cells, E:T ratio of 5:1, for 24 hours. ( B ) Internalization of NKG2A antibodies in NK cells, assessed by labeling the antibody with a pH-sensitive dye to monitor endocytosis. Durvalumab and pertuzumab (ptz IgG1) were included as controls. (A and B) Each symbol represents the value obtained from individual healthy donors. Significance was determined by one-way ANOVA with the Tukey’s post hoc test, * P < 0.05, ** P < 0.01, *** P < 0.001, and **** P < 0.0001.
Eamg Ld Il 2 Group, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/eamg ld il 2 group/product/MedChemExpress
Average 96 stars, based on 1 article reviews
eamg ld il 2 group - by Bioz Stars, 2026-02
96/100 stars
  Buy from Supplier
recombinant rat il 2  (MedChemExpress)
96
MedChemExpress recombinant rat il 2
( A ) The IFN-⍺ + , TNFα + , and GrzB + population (%) of <t>IL-2–activated</t> NK cells after antibodies treatment with different NKG2A binding valency (monovalent, bivalent, tetravalent, or multivalent) in the coculture system with A549 cells, E:T ratio of 5:1, for 24 hours. ( B ) Internalization of NKG2A antibodies in NK cells, assessed by labeling the antibody with a pH-sensitive dye to monitor endocytosis. Durvalumab and pertuzumab (ptz IgG1) were included as controls. (A and B) Each symbol represents the value obtained from individual healthy donors. Significance was determined by one-way ANOVA with the Tukey’s post hoc test, * P < 0.05, ** P < 0.01, *** P < 0.001, and **** P < 0.0001.
Recombinant Rat Il 2, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant rat il 2/product/MedChemExpress
Average 96 stars, based on 1 article reviews
recombinant rat il 2 - by Bioz Stars, 2026-02
96/100 stars
  Buy from Supplier

Image Search Results


( A ) The IFN-⍺ + , TNFα + , and GrzB + population (%) of IL-2–activated NK cells after antibodies treatment with different NKG2A binding valency (monovalent, bivalent, tetravalent, or multivalent) in the coculture system with A549 cells, E:T ratio of 5:1, for 24 hours. ( B ) Internalization of NKG2A antibodies in NK cells, assessed by labeling the antibody with a pH-sensitive dye to monitor endocytosis. Durvalumab and pertuzumab (ptz IgG1) were included as controls. (A and B) Each symbol represents the value obtained from individual healthy donors. Significance was determined by one-way ANOVA with the Tukey’s post hoc test, * P < 0.05, ** P < 0.01, *** P < 0.001, and **** P < 0.0001.

Journal: Science Advances

Article Title: Discovery and preclinical evaluation of monoclonal antibodies and bispecific engagers targeting the NKG2A inhibitory receptor

doi: 10.1126/sciadv.adu0690

Figure Lengend Snippet: ( A ) The IFN-⍺ + , TNFα + , and GrzB + population (%) of IL-2–activated NK cells after antibodies treatment with different NKG2A binding valency (monovalent, bivalent, tetravalent, or multivalent) in the coculture system with A549 cells, E:T ratio of 5:1, for 24 hours. ( B ) Internalization of NKG2A antibodies in NK cells, assessed by labeling the antibody with a pH-sensitive dye to monitor endocytosis. Durvalumab and pertuzumab (ptz IgG1) were included as controls. (A and B) Each symbol represents the value obtained from individual healthy donors. Significance was determined by one-way ANOVA with the Tukey’s post hoc test, * P < 0.05, ** P < 0.01, *** P < 0.001, and **** P < 0.0001.

Article Snippet: Primary NK cells were cultured with magnetic-activated cell sorting (MACS) basal NK media with supplementary (Miltenyi Biotec, 130-114-429), 10% (v/v) human serum (Sigma-Aldrich), and human IL-2 (hIL-2) (50 IU/ml; Miltenyi Biotec).

Techniques: Binding Assay, Labeling

( A ) CD16 + , NKG2A + , or NKG2C + population (%) of CD56 + NK cells after antibodies (100 nM) and IL-2 treatment (50 IU/ml) in the coculture system with A549 cells, E:T ratio of 5:1, for 24 hours. ( B ) Left: Graphs showing the cell killing activity of aHER2 × aNKG2A BiNK cotreatment with anti-HER2 IgG1 pertuzumab (ptz IgG1) in A549 and H2030 cells in the presence of primary NK cells. E:T ratio of 2:1. Right: Schematic figure of antibodies treatment schedule. (A) Each symbol represents the value obtained from individual healthy donors. Significance was determined by one-way ANOVA with the Tukey’s post hoc test, * P < 0.05 and ** P < 0.01.

Journal: Science Advances

Article Title: Discovery and preclinical evaluation of monoclonal antibodies and bispecific engagers targeting the NKG2A inhibitory receptor

doi: 10.1126/sciadv.adu0690

Figure Lengend Snippet: ( A ) CD16 + , NKG2A + , or NKG2C + population (%) of CD56 + NK cells after antibodies (100 nM) and IL-2 treatment (50 IU/ml) in the coculture system with A549 cells, E:T ratio of 5:1, for 24 hours. ( B ) Left: Graphs showing the cell killing activity of aHER2 × aNKG2A BiNK cotreatment with anti-HER2 IgG1 pertuzumab (ptz IgG1) in A549 and H2030 cells in the presence of primary NK cells. E:T ratio of 2:1. Right: Schematic figure of antibodies treatment schedule. (A) Each symbol represents the value obtained from individual healthy donors. Significance was determined by one-way ANOVA with the Tukey’s post hoc test, * P < 0.05 and ** P < 0.01.

Article Snippet: Primary NK cells were cultured with magnetic-activated cell sorting (MACS) basal NK media with supplementary (Miltenyi Biotec, 130-114-429), 10% (v/v) human serum (Sigma-Aldrich), and human IL-2 (hIL-2) (50 IU/ml; Miltenyi Biotec).

Techniques: Activity Assay